Synopsis of recent research by authors named "Run Qin"
- Run Qin's research primarily focuses on hematological malignancies, particularly chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL), exploring mechanisms of drug resistance and potential therapeutic strategies to overcome such resistance.
- Recent findings highlight the role of mTOR inhibition and HSP90 inhibitors in enhancing autophagy and addressing imatinib resistance in CML cells, contributing to a better understanding of treatment implications for resistant cases.
- Beyond hematological studies, Qin has also investigated food safety through innovative mass spectrometry techniques to track pesticide distribution in fruits and vegetables, and the impact of neonicotinoids on honeybees' health, illustrating a diverse research interest that merges oncology with environmental health.
